Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

[1]  R. Califf,et al.  Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.

[2]  F. Balestra,et al.  Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. GISSI--Avoidable Delay Study Group. , 1995, Archives of internal medicine.

[3]  R. Califf,et al.  Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[4]  M S Eisenberg,et al.  Reasons patients with chest pain delay or do not call 911. , 1995, Annals of emergency medicine.

[5]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[6]  J. Alpert,et al.  Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. , 1994, American heart journal.

[7]  R. Califf,et al.  More on the GUSTO Trial , 1994, Annals of Internal Medicine.

[8]  C. Fry,et al.  Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London , 1994, The Lancet.

[9]  T. Henry,et al.  Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction. , 1994, The American journal of cardiology.

[10]  D. Foster,et al.  Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. , 1994, The American journal of emergency medicine.

[11]  Johan Herlitz,et al.  Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .

[12]  P. Kudenchuk,et al.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. , 1993, JAMA.

[13]  Eric J. Topol,et al.  Illusion of Reperfusion Does Anyone Achieve Optimal Reperfusion During Acute Myocardial Infarction? , 1993, Circulation.

[14]  A. M. Skene,et al.  Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction , 1993, The Lancet.

[15]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[16]  L. Clark,et al.  Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention. , 1992, Journal of the National Medical Association.

[17]  P. Cummings.  Improving the time to thrombolytic therapy for myocardial infarction by using a quality assurance audit. , 1992, Annals of emergency medicine.

[18]  Eric J. Topol,et al.  A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction , 1992, Circulation.

[19]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[20]  D. Moser,et al.  Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction. , 1991, Heart & lung : the journal of critical care.

[21]  G. Taylor,et al.  Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. , 1991, The American journal of cardiology.

[22]  J. Herlitz,et al.  Components of delay time in suspected acute myocardial infarction with particular emphasis on patient delay , 1990, Journal of internal medicine.

[23]  J S Martin,et al.  Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. , 1990, American heart journal.

[24]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.

[25]  S. Schmidt,et al.  The prehospital phase of acute myocardial infarction in the era of thrombolysis. , 1990, The American journal of cardiology.

[26]  D. Chamberlain,et al.  Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. , 1990, European heart journal.

[27]  E. Ruiz,et al.  An analysis of time delays preceding thrombolysis for acute myocardial infarction. , 1989, JAMA.

[28]  M. Eisenberg,et al.  Delay between onset of chest pain and seeking medical care: the effect of public education. , 1989, Annals of emergency medicine.

[29]  L. Ekström,et al.  Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. , 1989, The American journal of cardiology.

[30]  B. Freedman,et al.  Factors influencing the time from onset of chest pain to arrival at hospital , 1989, The Medical journal of Australia.

[31]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[32]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[33]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[34]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[35]  M. Gotsman,et al.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.

[36]  F. Sheehan,et al.  Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. , 1985, Journal of the American College of Cardiology.

[37]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[38]  W. Mitic,et al.  The effect of a media campaign on heart attack delay and decision times. , 1984, Canadian journal of public health = Revue canadienne de sante publique.

[39]  J. Lowe,et al.  The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.

[40]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .